From the German Center for Neurodegenerative Diseases (DZNE) (S.J.T., M.J.G.); Department of Psychosomatic Medicine (S.J.T., H.-C.F.), University Medicine Rostock, Germany; and Instituto de Biomedicina de Sevilla (IBiS) (M.J.G.), Unidad de Trastornos del Movimiento, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Spain.
Neurology. 2020 Sep 8;95(10):e1301-e1311. doi: 10.1212/WNL.0000000000010192. Epub 2020 Jul 6.
To study the neuropathologic correlates of cholinergic basal forebrain (BF) atrophy as determined using antemortem MRI in the Alzheimer disease (AD) spectrum.
We determined associations between BF volume from antemortem MRI brain scans and postmortem assessment of neuropathologic features, including neuritic plaques, neurofibrillary tangles (NFTs), Lewy body (LB) pathology, and TDP-43, in 64 cases of the Alzheimer's Disease Neuroimaging Initiative cohort. For comparison, we assessed neuropathologic features associated with hippocampal and parahippocampal gyrus atrophy. In addition to region of interest-based analysis, we determined the association of neuropathologic features with whole brain gray matter volume using regionally unbiased voxel-based volumetry.
BF atrophy was associated with Thal amyloid phases (95% confidence interval [CI] -0.49 to -0.01, = 0.049) and presence of LB pathology (95% CI -0.54 to -0.06, = 0.015), as well as with the degree of LB pathology within the nucleus basalis Meynert (95% CI -0.54 to -0.07, = 0.025). These effects were no longer significant after false discovery rate (FDR) correction. Hippocampal atrophy was significantly associated with the presence of TDP-43 pathology (95% CI -0.61 to -0.17, = 0.003; surviving FDR correction), in addition to dentate gyrus NFT load (95% CI -0.49 to -0.01, = 0.044; uncorrected). Voxel-based analysis confirmed spatially restricted effects of Thal phases and presence of LB pathology on BF volume.
These findings indicate that neuropathologic correlates of regional atrophy differ substantially between different brain regions that are typically involved in AD-related neurodegeneration, including different susceptibilities to common comorbid pathologies.
研究使用阿尔茨海默病(AD)谱中的生前 MRI 确定的胆碱能基底前脑(BF)萎缩的神经病理学相关性。
我们确定了 64 例阿尔茨海默病神经影像学倡议队列中生前 MRI 脑扫描 BF 体积与死后评估的神经病理学特征(包括神经原纤维缠结、神经纤维缠结(NFT)、路易体(LB)病理学和 TDP-43)之间的关联。为了比较,我们评估了与海马和海马旁回萎缩相关的神经病理学特征。除了基于感兴趣区域的分析外,我们还使用区域无偏体素容积测量法确定了神经病理学特征与全脑灰质体积的相关性。
BF 萎缩与 Thal 淀粉样蛋白阶段(95%置信区间 [CI] -0.49 至 -0.01, = 0.049)和 LB 病理学的存在(95%CI -0.54 至 -0.06, = 0.015)相关,以及核基底 Meynert 内 LB 病理学的程度(95%CI -0.54 至 -0.07, = 0.025)。在错误发现率(FDR)校正后,这些影响不再显著。海马萎缩与 TDP-43 病理学的存在显著相关(95%CI -0.61 至 -0.17, = 0.003;幸存的 FDR 校正),除了齿状回 NFT 负荷(95%CI -0.49 至 -0.01, = 0.044;未校正)。基于体素的分析证实了 Thal 阶段和 LB 病理学存在对 BF 体积的空间限制效应。
这些发现表明,不同脑区(包括对常见共病病理学的不同易感性)的区域萎缩的神经病理学相关性有很大差异。